WijkstraPJ, JonesPW. Quality of life in patients with COPD. In: PostmaDS, SiafakasNM, editors. Management of chronic obstructive pulmonary disease. Eur Respir Mon1998;7:235–246.
4.
JonesPW, QuirkFH, BaveystockCM, LittlejohnsP.A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis1992;145(6):1321–1327.
RourkeSB, GrantI, RippethJD. Neuropsychiatric aspects of hypoxemia and the treatment effects of long term oxygen therapy. In: O'DonohueWJJr, editor. Long-term oxygen therapy. Lung biology in health and disease. New York: Marcel Dekker; 1995:129–150.
7.
KropHD, BlockAJ, CohenE.Neuropsychologic effects of continuous oxygen therapy in chronic obstructive pulmonary disease. Chest1973;64(3):317–322.
8.
BorakJ, SliwinskiP, PiaseckiZ, ZielinskiJ.Psychological status of COPD patients on long term oxygen therapy. Eur Respir J1991;4(1):59–62.
9.
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease: a clinical trial. Ann Intern Med1980;93(3):391–398.
10.
Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med1983;99(5):612–620.
11.
GrantI, PrigatanoGP, HeatonRK, McSweenyAJ, WrightEC, AdamsKM. Progressive neuropsychologic impairment and hypoxemia: relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry1987;44(11):999–1006.
12.
HeatonRK, GrantI, McSweenyAJ, AdamsKM, PettyTL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med1983;143(10):1941–1947.
13.
BergnerM, BobbittRA, CarterWB, GilsonBS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care1981;19(8):787–805.
14.
StewartAL, HaysRD, WareJEJr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care1988;26(7):724–735.
15.
KaplanRM, AtkinsCJ, TimmsR.Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis1984;37(2):85–95.
16.
PrigatanoGP, WrightEC, LevinD.Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med1984;144(8):1613–1619.
17.
JonesPW. Quality of life measurement for patients with diseases of the airways. Thorax1991;46(9):676–682.
18.
RiesAL, KaplanRM, LimbergTM, PrewittLM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med1995;122(11):823–832.
19.
GuyattGH, BermanLB, TownsendM, PugsleySO, ChambersLW. A measure of quality of life for clinical trials in chronic lung disease. Thorax1987;42(10):773–778.
20.
LacasseY, WongE, GuyattGH, KingD, CookDJ, GoldsteinRS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet1996;348(9035):1115–1119.
21.
WedzichaJA, BestallJC, GarrodR, GarnhamR, PaulEA, JonesPW. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J1998;12(2):363–369.
22.
Meecham JonesDJ, PaulEA, JonesPW, WedzichaJA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med1995;152(2):538–544.
23.
JonesPW, BoshTK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med1997;155(4):1283–1289.
24.
OkubadejoAA, JonesPW, WedzichaJA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax1996;51(1):44–47.
25.
SeemungalTAR, DonaldsonGC, PaulEA, BestallJC, JeffriesDJ, WedzichaJA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med1998;157(5 Pt 1):1418–1422.
26.
OkubadejoAA, PaulEA, JonesPW, WedzichaJA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia?Eur Respir J1996;9(11):2335–2339.
27.
McNairDM, LorrM, DroppelmanLF. EDITS manual for the profile of mood states. San Diego: Educational and Industrial Testing Service; 1971.
28.
LahdensuoA, OjanenM, AhonenA, LaitinenJ, PoppiusH, SalorinneY, et al. Psychosocial effects of continuous oxygen therapy in hypoxaemic chronic obstructive pulmonary disease patients. Eur Respir J1989;2(10):977–980.
29.
DilworthJP, HiggsCMB, JonesPA, WhiteRJ. Acceptability of oxygen concentrators: the patient's view. Br J Gen Pract1990;40(339):415–417.
30.
ZigmondAS, SnaithRP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand1983;67(6):361–370.
31.
LockSH, BlowerG, PrynneM, WedzichaJA. Comparison of liquid and gaseous oxygen for domiciliary portable use. Thorax1992;47(2):98–100.
32.
AnderssonA, StromK, BrodinH, AltonM, BomanG, KakobssonP, et al. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J1998;12(6):1284–1289.
33.
RestrickLJ, PaulEA, BraidGM, CullinanP, Moore-GillonJ, WedzichaJA. Assessment and follow up of patients prescribed long term oxygen therapy. Thorax1993;48(7):708–713.
34.
NouriFM, LincolnNB. An extended activities of daily living scale for stroke patients. Clin Rehabil1987;1:301–305.
35.
GarnhamR, BestallJ, GarrodR, PaulEA, JonesPW, WedzichaJA. Relationship between laboratory measures of impairment and measures of disturbance of daily living in patients with COPD (abstract). Thorax1995;50:A55.
36.
OkubadejoAA, O'SheaL, JonesPW, WedzichaJA. Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J1997;10(7):1572–1575.